{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:10:33Z","timestamp":1775063433633,"version":"3.50.1"},"reference-count":20,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Guy's and St Thomas\u2019 NHS Foundation Trust"},{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,26]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Colchicine has been shown to reduce cardiovascular events and may improve outcomes in arteriovenous fistulas used for haemodialysis due to antiproliferative effects. However, it is often avoided in patients receiving dialysis. Therefore, a large trial assessing the potential benefits of colchicine in dialysis patients cannot begin without further data on feasibility. The primary objective of this study is to assess the feasibility of carrying out future trials of colchicine in dialysis patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is an open-label, single centre, single arm study with 100 participants. The primary outcome is feasibility and the decision to progress to a full-scale trial. This will be based on the consent rate and the colchicine discontinuation rate. Secondary objectives are testing the feasibility of data collection procedures relating to quality-of-life measures, vascular access interventions and safety. Other secondary objectives are to assess the utility of the electronic health record for collecting trial data and to explore patients\u2019 and healthcare providers\u2019 experiences and attitudes towards colchicine and a feasibility study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has Research Ethics Committee approval (Wales REC 6; 24\/WA\/0277). It is intended that the results of the study will be reported in peer-reviewed scientific journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN91308625\">ISRCTN91308625<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-113028","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:25:30Z","timestamp":1775057130000},"page":"e113028","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Colchicine and dialysis patients (CAD): protocol for a feasibility study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"isrctn91308625","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5147-8069","authenticated-orcid":false,"given":"Yuen Ting Dorothy","family":"Wong","sequence":"first","affiliation":[{"name":"King\u2019s College London, London, UK"},{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4907-0168","authenticated-orcid":false,"given":"Lyndsay Dawn","family":"Hughes","sequence":"additional","affiliation":[{"name":"King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Norton","sequence":"additional","affiliation":[{"name":"King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-1353","authenticated-orcid":false,"given":"Michael Gregory","family":"Robson","sequence":"additional","affiliation":[{"name":"King\u2019s College London, London, UK"},{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2026040108252069000_16.4.e113028.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372"},{"key":"2026040108252069000_16.4.e113028.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912388"},{"key":"2026040108252069000_16.4.e113028.3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy174"},{"key":"2026040108252069000_16.4.e113028.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.07.019"},{"key":"2026040108252069000_16.4.e113028.5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/1129729819845991","article-title":"Factors associated with outcome after successful radiological intervention in arteriovenous fistulas: A retrospective cohort","volume":"20","author":"Manou-Stathopoulou","year":"2019","journal-title":"J Vasc Access"},{"key":"2026040108252069000_16.4.e113028.6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2322030714"},{"key":"2026040108252069000_16.4.e113028.7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.218.3.r01mr38711","article-title":"Brachial arterial access: endovascular treatment of failing Brescia-Cimino hemodialysis fistulas--initial success and long-term results","volume":"218","author":"Manninen","year":"2001","journal-title":"Radiology"},{"key":"2026040108252069000_16.4.e113028.8","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.ejrad.2011.09.004","article-title":"Factors influencing technical success and outcome of percutaneous balloon angioplasty in de novo native hemodialysis arteriovenous fistulas","volume":"81","author":"Heye","year":"2012","journal-title":"Eur J Radiol"},{"key":"2026040108252069000_16.4.e113028.9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5152\/dir.2014.14348","article-title":"Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency","volume":"21","author":"Aktas","year":"2015","journal-title":"Diagn Interv Radiol"},{"key":"2026040108252069000_16.4.e113028.10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.12.2029"},{"key":"2026040108252069000_16.4.e113028.11","article-title":"Is Repeat PTA of a Failing Hemodialysis Fistula Durable?","volume":"2014","author":"Bountouris","year":"2014","journal-title":"Int J Vasc Med"},{"key":"2026040108252069000_16.4.e113028.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914617"},{"key":"2026040108252069000_16.4.e113028.13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.kint.2021.02.040","article-title":"A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas","volume":"100","author":"Karunanithy","year":"2021","journal-title":"Kidney Int"},{"key":"2026040108252069000_16.4.e113028.14","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2215\/CJN.14231217","article-title":"Drug Coated Balloon Angioplasty in Failing AV Fistulas: A Randomized Controlled Trial","volume":"13","author":"Trerotola","year":"2018","journal-title":"Clin J Am Soc Nephro"},{"key":"2026040108252069000_16.4.e113028.15","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.121.056171"},{"key":"2026040108252069000_16.4.e113028.16","doi-asserted-by":"crossref","unstructured":"Stewart S , Yang KCK , Atkins K , et al . Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 2020;22. doi:10.1186\/s13075-020-2120-7","DOI":"10.1186\/s13075-020-2120-7"},{"key":"2026040108252069000_16.4.e113028.17","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/MJT.0b013e31825a364a","article-title":"Colchicine toxicity in end-stage renal disease patients: a case-control study","volume":"21","author":"Solak","year":"2014","journal-title":"Am J Ther"},{"key":"2026040108252069000_16.4.e113028.18","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0238-6"},{"key":"2026040108252069000_16.4.e113028.19","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14193"},{"key":"2026040108252069000_16.4.e113028.20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/11297298211046746","article-title":"Validation of a vascular access specific quality of life measure (VASQoL)","volume":"24","author":"Richarz","year":"2023","journal-title":"J Vasc Access"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-113028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:25:33Z","timestamp":1775057133000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-113028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjopen-2025-113028"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-113028","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}